AMILI is a company at the forefront of microbiome research and healthcare innovation, aiming to help us reshape the way we think about our gut health.
As Asia’s first and only gut microbiome transplant bank, AMILI is on a mission to build the world’s largest multi-ethnic microbiome database, focusing specifically on the diverse populations of Southeast Asia.
On The Right Business, Hongbin Jeong speaks with Zat, Editor-in-Chief, The Peak Singapore to find out more.

Budget 2026: What are the biggest opportunities for mid-career workers from Budget 2026
16:19

Wealth Tracker: What makes certain watches a "blue-chip" investment?
15:52

What’s Trending: Will you use your ang bao money to buy gold and are humanoids about to do more CNY performances?
16:42